MOG35-55
Myelin oligodendrocyte glycoprotein 35-55
21 Amino Acids · MW: ~2618 Da
Amino Acids
21
Molecular Weight
~2618 Da
Half-life
minutes to hours
Research Score
4.2
Studies
92
Storage
Store lyophilized at -20°C, reconstituted at 2-8°C
What is MOG35-55?
A widely used myelin oligodendrocyte glycoprotein peptide in experimental autoimmune encephalomyelitis. It is used to study tolerogenic vaccination, Treg induction, and antigen-specific immune deviation.
Key Benefits & Mechanisms
tolerogenic vaccination
Treg induction
immune deviation
Research Summary
One of the most common peptide antigens for autoimmune demyelination research. It is frequently used to assess whether peptide-based therapy can reprogram pathogenic T-cell responses.
Related Peptides
P140
Phosphorylated U1-70K-derived peptide (Lupuzor)
A synthetic phosphopeptide from the spliceosomal U1-70K protein studied as an immune-tolerizing therapy for systemic lupus erythematosus. It aims to restore antigen-specific tolerance rather than broadly suppress immunity.
AutoimmunehCDR1
Human complementarity-determining region 1 peptide (Edratide)
A synthetic 19-mer derived from a human anti-DNA antibody sequence and developed as an immunomodulatory peptide for SLE. It has been studied for dampening pathogenic anti-dsDNA responses and restoring immune balance.
AutoimmunednaJP1
dnaJ heat-shock protein 70-derived peptide
A synthetic peptide derived from the bacterial dnaJ/heat-shock protein family that was evaluated as an antigen-specific therapy in rheumatoid arthritis. The concept is to induce regulatory immune responses to shared heat-shock protein epitopes.
AutoimmuneCII 259-273
Type II collagen peptide 259-273
An immunodominant collagen II epitope used in experimental and translational rheumatoid arthritis tolerance strategies. It is designed to retrain the immune system against joint-specific autoantigen rather than suppressing immunity broadly.
Autoimmune